These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1452192)

  • 1. [Recent findings on the pathogenicity of Entamoeba histolytica].
    Tannich E; Leippe M; Horstmann RD
    Immun Infekt; 1992 Oct; 20(5):146-50. PubMed ID: 1452192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in the molecular biology of Entamoeba histolytica.
    Horstmann RD; Leippe M; Tannich E
    Trop Med Parasitol; 1992 Dec; 43(4):213-8. PubMed ID: 1338130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity.
    Campos-Rodríguezp R; Jarillo-Luna A
    Parasite Immunol; 2005; 27(1-2):1-8. PubMed ID: 15813717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host tissue destruction by Entamoeba histolytica: molecules mediating adhesion, cytolysis, and proteolysis.
    Horstmann RD; Leippe M; Tannich E
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():57-60. PubMed ID: 1342717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Royal Society of Tropical Medicine and Hygiene Meeting at Manson House, London, 19 February 1998. Amoebic disease. Entamoeba histolytica and E. dispar: comparison of molecules considered important for host tissue destruction.
    Tannich E
    Trans R Soc Trop Med Hyg; 1998; 92(6):593-6. PubMed ID: 10326098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The galactose-inhibitable surface lectin of Entamoeba histolytica, a possible candidate for a subunit vaccine to prevent amoebiasis.
    Lotter H; Tannich E
    Behring Inst Mitt; 1997 Mar; (99):112-6. PubMed ID: 9303210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent discoveries in the pathogenesis and immune response toward Entamoeba histolytica.
    Lejeune M; Rybicka JM; Chadee K
    Future Microbiol; 2009 Feb; 4(1):105-18. PubMed ID: 19207103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced pro-inflammatory chemokine/cytokine response triggered by pathogenic Entamoeba histolytica : basis of invasive disease.
    Sharma M; Vohra H; Bhasin D
    Parasitology; 2005 Dec; 131(Pt 6):783-96. PubMed ID: 16336732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ex-vivo human intestinal model to study Entamoeba histolytica pathogenesis.
    Bansal D; Ave P; Kerneis S; Frileux P; Boché O; Baglin AC; Dubost G; Leguern AS; Prevost MC; Bracha R; Mirelman D; Guillén N; Labruyère E
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e551. PubMed ID: 19936071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica.
    Tannich E; Horstmann RD; Knobloch J; Arnold HH
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5118-22. PubMed ID: 2544890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of surface glycoconjugates on Entamoeba histolytica and Entamoeba dispar.
    Pacheco-Yépez J; Campos-Rodríguez R; Rojas-Hernández S; Serrano-Luna JJ; Rivera-Aguilar V; Villa-Treviño S; Martínez-Palomo A; Tsutsumi V; Shibayama M
    Parasitol Int; 2009 Jun; 58(2):171-7. PubMed ID: 19269346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine proteinases and the pathogenesis of amebiasis.
    Que X; Reed SL
    Clin Microbiol Rev; 2000 Apr; 13(2):196-206. PubMed ID: 10755997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulence factors of Entamoeba histolytica.
    Gilchrist CA; Petri WA
    Curr Opin Microbiol; 1999 Aug; 2(4):433-7. PubMed ID: 10458982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunopathogenesis of Entamoeba histolytica.
    Mortimer L; Chadee K
    Exp Parasitol; 2010 Nov; 126(3):366-80. PubMed ID: 20303955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity prevents tissue invasion by Entamoeba histolytica.
    Shibayama M; Rivera-Aguilar V; Barbosa-Cabrera E; Rojas-Hernández S; Jarillo-Luna A; Tsutsumi V; Pacheco-Yepez J; Campos-Rodríguez R
    Can J Microbiol; 2008 Dec; 54(12):1032-42. PubMed ID: 19096458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human liver sinusoidal endothelial cells respond to interaction with Entamoeba histolytica by changes in morphology, integrin signalling and cell death.
    Faust DM; Marquay Markiewicz J; Danckaert A; Soubigou G; Guillen N
    Cell Microbiol; 2011 Jul; 13(7):1091-106. PubMed ID: 21624031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pore-forming peptide of Entamoeba histolytica, the protozoan parasite causing human amoebiasis.
    Leippe M; Müller-Eberhard HJ
    Toxicology; 1994 Feb; 87(1-3):5-18. PubMed ID: 7512763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Response to the Enteric Parasite
    Uribe-Querol E; Rosales C
    Physiology (Bethesda); 2020 Jul; 35(4):244-260. PubMed ID: 32490746
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of endogenous Cysteine Protease Inhibitor (ICP) 1 expression in Entamoeba histolytica affects amoebic adhesion to Extracellular Matrix proteins.
    Lee YA; Saito-Nakano Y; Kim KA; Min A; Nozaki T; Shin MH
    Exp Parasitol; 2015 Feb; 149():7-15. PubMed ID: 25500214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence and virulence factors in Entamoeba histolytica, the agent of human amoebiasis.
    Faust DM; Guillen N
    Microbes Infect; 2012 Dec; 14(15):1428-41. PubMed ID: 22710276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.